The Latest Breaking News from FDA

Lawmakers blasted the FDA for not cracking down on illegal vapes, with one telling the FDA "you have completely fallen down on the job."

Senate Judiciary Committee to discuss surge of illegal e-cigarettes in the US, focusing on regulatory challenges and underage vaping concerns.

In the past decade, CVS hired at least 15 drug makers with previous manufacturing issues, according to a Bloomberg investigation.

Policies that increase the use of traditional cigarettes are unlikely to improve public health.

Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.

The healthcare sector is expected to grow rapidly due to the growing need for precision drugs, the rising elderly population, government initiatives, and increasing chronic diseases. Against this backdrop, investors could consider buying fundamentally strong, undervalued healthcare stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead Sciences (GILD). Read…

FDA and Justice Department join forces to crack down on illegal e-cigarette sales in the U.S., targeting unauthorized vaping products and manufacturers.

The drug is already approved for limited use in Australia to treat PTSD and depression.

FDA has issued a warning after six people were hospitalized across four states following the consumption of Diamond Shruumz-brand's microdosing chocolate bars.